Huanjun Yang

机构：Shanghai Medical College of Fudan University, Fudan University Shanghai Cancer Center, Shanghai Institute of Hematology, Shanghai Clinical Research Center

发表论文 28 篇 · 总被引 1881 次 · h-index 12

代表论文

• Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial (2018 · Journal of Clinical Oncology · 被引 1004)
• Long-term Efficacy of Neoadjuvant Chemoradiotherapy Plus Surgery for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma (2021 · JAMA Surgery · 被引 354)
• Systemic therapy with or without local intervention for oligometastatic oesophageal squamous cell carcinoma (ESO-Shanghai 13): an open-label, randomised, phase 2 trial (2023 · ˜The œLancet. Gastroenterology & hepatology · 被引 82)
• Comparison of 3 Paclitaxel-Based Chemoradiotherapy Regimens for Patients With Locally Advanced Esophageal Squamous Cell Cancer (2022 · JAMA Network Open · 被引 73)
• Impact of Lymph Node Dissection on Survival After Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma (2021 · Annals of Surgery · 被引 51)
• Pathological complete response after neoadjuvant treatment determines survival in esophageal squamous cell carcinoma patients (NEOCRTEC5010) (2021 · Annals of Translational Medicine · 被引 43)